Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
UK vaccines network: Mapping priority pathogens of epidemic potential and vaccine pipeline developments
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
covidontheweb.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
UK vaccines network: Mapping priority pathogens of epidemic potential and vaccine pipeline developments
Creator
Entrican, Gary
Hewson, Roger
Prior, Joann
Simpson, Andrew
Simpson, Karl
Gilbert, Sarah
Carroll, Miles
Fooks, Anthony
Hosie, Margaret
Whitty, Christopher
Kinsey, Anna
Noad, Rob
Stevens, Mark
Source
Elsevier; Medline; PMC
abstract
Abstract During the 2013–2016 Ebola outbreak in West Africa an expert panel was established on the instructions of the UK Prime Minister to identify priority pathogens for outbreak diseases that had the potential to cause future epidemics. A total of 13 priority pathogens were identified, which led to the prioritisation of spending in emerging diseases vaccine research and development from the UK. This meeting report summarises the process used to develop the UK pathogen priority list, compares it to lists generated by other organisations (World Health Organisation, National Institutes of Allergy and Infectious Diseases) and summarises clinical progress towards the development of vaccines against priority diseases. There is clear technical progress towards the development of vaccines. However, the availability of these vaccines will be dependent on sustained funding for clinical trials and the preparation of clinically acceptable manufactured material during inter-epidemic periods.
has issue date
2019-10-08
(
xsd:dateTime
)
bibo:doi
10.1016/j.vaccine.2019.09.009
bibo:pmid
31522809
has license
els-covid
sha1sum (hex)
81230f87c0f91c179b1111a9d7841b3426bd4a51
schema:url
https://doi.org/10.1016/j.vaccine.2019.09.009
resource representing a document's title
UK vaccines network: Mapping priority pathogens of epidemic potential and vaccine pipeline developments
has PubMed Central identifier
PMC7127063
has PubMed identifier
31522809
schema:publication
Vaccine
resource representing a document's body
covid:81230f87c0f91c179b1111a9d7841b3426bd4a51#body_text
is
schema:about
of
named entity 'VACCINES'
named entity 'VACCINES'
named entity 'DEVELOPMENT'
named entity 'SUSTAINED'
named entity 'NATIONAL'
named entity 'LED'
named entity 'PROCESS'
named entity 'OUTBREAK'
named entity 'PATHOGENS'
named entity 'TECHNICAL'
named entity 'IDENTIFIED'
named entity 'SPENDING'
named entity 'INTER-'
named entity 'FUNDING'
named entity 'LIST'
named entity 'pathogens'
named entity 'epidemic'
named entity 'pathogens'
named entity 'developments'
named entity 'NETWORK'
named entity 'EBOLA'
named entity 'EPIDEMIC'
named entity 'MEETING REPORT'
named entity 'CLINICAL'
named entity 'VACCINE'
named entity 'THESE'
named entity 'ALLERGY'
named entity 'PANEL'
named entity 'ORGANISATION'
named entity 'POTENTIAL'
named entity 'GENERATED'
named entity 'TO IDENTIFY'
named entity 'ESTABLISHED'
named entity 'PERIODS'
named entity 'CAUSE'
named entity 'PATHOGEN'
named entity 'CONFERENCE REPORT'
named entity 'MAPPING'
named entity 'DEVELOPMENTS'
named entity 'PRIORITY'
named entity 'PATHOGENS'
named entity 'CLEAR'
named entity 'INSTRUCTIONS'
named entity 'USED'
named entity 'PREPARATION'
named entity 'MANUFACTURED MATERIAL'
named entity 'VACCINE RESEARCH'
named entity 'PRIORITY'
named entity 'DISEASES'
named entity 'EPIDEMIC'
named entity 'PIPELINE'
named entity 'POTENTIAL'
named entity 'PROGRESS'
named entity 'WEST AFRICA'
named entity 'TOTAL'
named entity 'ACCEPTABLE'
named entity 'CLINICAL TRIALS'
named entity 'PRIME MINISTER'
named entity 'INSTITUTES'
named entity 'INFECTIOUS DISEASES'
named entity 'AVAILABILITY OF'
named entity 'FUTURE'
named entity 'DEPENDENT'
named entity 'EPIDEMICS'
named entity 'HEALTH'
named entity 'RESEARCH AND DEVELOPMENT'
named entity 'Infectious Diseases'
named entity 'Ebola'
named entity 'develop'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 6
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software